Inactive Ingredient Search for Approved Drug Products
Search Names Beginning with M
| Inactive Ingredient | Route | Dosage Form | CAS Number | UNII | Maximum Potency per unit dose | Maximum Daily Exposure (MDE) | Record Updated |
|---|---|---|---|---|---|---|---|
| MAGNESIUM ALUMINOMETASILICATE TYPE IA | ORAL | TABLET | 7LVU907546 | 69mg | |||
| MAGNESIUM ALUMINOMETASILICATE TYPE IA | ORAL | TABLET, FILM COATED | 7LVU907546 | 2mg | |||
| MAGNESIUM ALUMINUM SILICATE | DENTAL | PASTE, DENTIFRICE | 1327431 | 6M3P64V0NC | 0.4%w/w | ||
| MAGNESIUM ALUMINUM SILICATE | ORAL | CAPSULE | 1327431 | 6M3P64V0NC | 60mg | ||
| MAGNESIUM ALUMINUM SILICATE | ORAL | CONCENTRATE | 1327431 | 6M3P64V0NC | 410mg/5ml | ||
| MAGNESIUM ALUMINUM SILICATE | ORAL | GRANULE, FOR SUSPENSION | 1327431 | 6M3P64V0NC | 12.5mg/5ml | ||
| MAGNESIUM ALUMINUM SILICATE | ORAL | LIQUID | 1327431 | 6M3P64V0NC | 82mg/5ml | ||
| MAGNESIUM ALUMINUM SILICATE | ORAL | POWDER, FOR SUSPENSION | 1327431 | 6M3P64V0NC | NA | ||
| MAGNESIUM ALUMINUM SILICATE | ORAL | SUSPENSION | 1327431 | 6M3P64V0NC | 5000mg/5ml | ||
| MAGNESIUM ALUMINUM SILICATE | ORAL | SUSPENSION/ DROPS | 1327431 | 6M3P64V0NC | 4.15mg/2.5ml | ||
| MAGNESIUM ALUMINUM SILICATE | ORAL | SYRUP | 1327431 | 6M3P64V0NC | 100mg/1ml | ||
| MAGNESIUM ALUMINUM SILICATE | ORAL | TABLET | 1327431 | 6M3P64V0NC | 60mg | ||
| MAGNESIUM ALUMINUM SILICATE | ORAL | TABLET, CHEWABLE | 1327431 | 6M3P64V0NC | 12mg | ||
| MAGNESIUM ALUMINUM SILICATE | ORAL | TABLET, EXTENDED RELEASE | 1327431 | 6M3P64V0NC | 70mg | ||
| MAGNESIUM ALUMINUM SILICATE | RECTAL | SUSPENSION | 1327431 | 6M3P64V0NC | 14480mg | ||
| MAGNESIUM ALUMINUM SILICATE | TOPICAL | CREAM | 1327431 | 6M3P64V0NC | 1.5%w/w | ||
| MAGNESIUM ALUMINUM SILICATE | TOPICAL | CREAM, AUGMENTED | 1327431 | 6M3P64V0NC | 3%w/w | ||
| MAGNESIUM ALUMINUM SILICATE | TOPICAL | LOTION | 1327431 | 6M3P64V0NC | 1.5%w/w | ||
| MAGNESIUM ALUMINUM SILICATE | TOPICAL | SHAMPOO | 1327431 | 6M3P64V0NC | 1.25%w/w | ||
| MAGNESIUM ALUMINUM SILICATE | VAGINAL | OINTMENT | 1327431 | 6M3P64V0NC | 5.39%w/w | ||
| MAGNESIUM ALUMINUM SILICATE TYPE IC | ORAL | SUSPENSION | XLI9KNX1FT | 138mg | |||
| MAGNESIUM ALUMINUM SILICATE TYPE IIA | ORAL | SUSPENSION | II0CAA4909 | 320mg | |||
| MAGNESIUM CARBONATE | ORAL | CAPSULE | 17968262 | 0E53J927NA | 22.4mg | ||
| MAGNESIUM CARBONATE | ORAL | CAPSULE, COATED PELLETS | 17968262 | 0E53J927NA | 22.4mg | ||
| MAGNESIUM CARBONATE | ORAL | CAPSULE, DELAYED RELEASE | 17968262 | 0E53J927NA | 180mg | ||
| MAGNESIUM CARBONATE | ORAL | CAPSULE, EXTENDED RELEASE | 17968262 | 0E53J927NA | 180mg | ||
| MAGNESIUM CARBONATE | ORAL | TABLET | 17968262 | 0E53J927NA | 500mg | ||
| MAGNESIUM CARBONATE | ORAL | TABLET, CHEWABLE | 17968262 | 0E53J927NA | 100mg | ||
| MAGNESIUM CARBONATE | ORAL | TABLET, COATED | 17968262 | 0E53J927NA | 28.5mg | ||
| MAGNESIUM CARBONATE | ORAL | TABLET, DELAYED RELEASE | 17968262 | 0E53J927NA | 250mg | ||
| MAGNESIUM CARBONATE | ORAL | TABLET, EXTENDED RELEASE | 17968262 | 0E53J927NA | 11.22mg | ||
| MAGNESIUM CARBONATE | ORAL | TABLET, FILM COATED | 17968262 | 0E53J927NA | 500mg | ||
| MAGNESIUM CARBONATE | ORAL | TABLET, ORALLY DISINTEGRATING | 17968262 | 0E53J927NA | 120mg | ||
| MAGNESIUM CARBONATE | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 17968262 | 0E53J927NA | 84mg | ||
| MAGNESIUM CHLORIDE | AURICULAR (OTIC) | SUSPENSION | 7791186 | 02F3473H9O | 0.06%w/w | ||
| MAGNESIUM CHLORIDE | INTRAOCULAR | SOLUTION | 7791186 | 02F3473H9O | 0.3mg | ||
| MAGNESIUM CHLORIDE | INTRAPERITONEAL | SOLUTION | 7791186 | 02F3473H9O | 0.01%w/v | ||
| MAGNESIUM CHLORIDE | INTRATHECAL | INJECTION, SOLUTION | 7791186 | 02F3473H9O | 1mg | ||
| MAGNESIUM CHLORIDE | INTRAVITREAL | INJECTION, SUSPENSION | 7791186 | 02F3473H9O | 0.03%w/v | ||
| MAGNESIUM CHLORIDE | OPHTHALMIC | SOLUTION | 7791186 | 02F3473H9O | 0.01%w/v | ||
| MAGNESIUM CHLORIDE | OPHTHALMIC | SOLUTION/ DROPS | 7791186 | 02F3473H9O | 0.03%w/v | ||
| MAGNESIUM HYDROXIDE | ORAL | CAPSULE, DELAYED RELEASE | 1309428 | NBZ3QY004S | 6.7mg | ||
| MAGNESIUM HYDROXIDE | ORAL | POWDER, FOR SUSPENSION | 1309428 | NBZ3QY004S | 0.01mg | ||
| MAGNESIUM HYDROXIDE | ORAL | TABLET | 1309428 | NBZ3QY004S | 120mg | ||
| MAGNESIUM HYDROXIDE | ORAL | TABLET, CHEWABLE | 1309428 | NBZ3QY004S | 750mg | ||
| MAGNESIUM HYDROXIDE | ORAL | TABLET, DELAYED RELEASE | 1309428 | NBZ3QY004S | 150mg | ||
| MAGNESIUM HYDROXIDE | ORAL | TABLET, FILM COATED | 1309428 | NBZ3QY004S | 43.4mg | ||
| MAGNESIUM NITRATE | TOPICAL | CREAM | 10377603 | 77CBG3UN78 | NA | ||
| MAGNESIUM NITRATE | TOPICAL | LOTION | 10377603 | 77CBG3UN78 | NA | ||
| MAGNESIUM OXIDE | BUCCAL | GUM, CHEWING | 1309484 | 3A3U0GI71G | 173mg | ||
| MAGNESIUM OXIDE | ORAL | CAPSULE | 1309484 | 3A3U0GI71G | 20mg | ||
| MAGNESIUM OXIDE | ORAL | CAPSULE, DELAYED RELEASE | 1309484 | 3A3U0GI71G | 78mg | ||
| MAGNESIUM OXIDE | ORAL | CAPSULE, EXTENDED RELEASE | 1309484 | 3A3U0GI71G | 75mg | ||
| MAGNESIUM OXIDE | ORAL | TABLET | 1309484 | 3A3U0GI71G | 63mg | ||
| MAGNESIUM OXIDE | ORAL | TABLET, DELAYED RELEASE | 1309484 | 3A3U0GI71G | 368mg | ||
| MAGNESIUM OXIDE | ORAL | TABLET, EXTENDED RELEASE | 1309484 | 3A3U0GI71G | 25.74mg | ||
| MAGNESIUM OXIDE | ORAL | TABLET, FILM COATED | 1309484 | 3A3U0GI71G | 80mg | ||
| MAGNESIUM OXIDE | SUBLINGUAL | TABLET | 1309484 | 3A3U0GI71G | 15mg | ||
| MAGNESIUM SILICATE | DENTAL | PASTE, DENTIFRICE | 1343880 | 9B9691B2N9 | 0.4%w/w | ||
| MAGNESIUM SILICATE | ORAL | CAPSULE | 1343880 | 9B9691B2N9 | 40mg | ||
| MAGNESIUM SILICATE | ORAL | TABLET | 1343880 | 9B9691B2N9 | 10mg | ||
| MAGNESIUM SILICATE | ORAL | TABLET, CHEWABLE | 1343880 | 9B9691B2N9 | 30mg | ||
| MAGNESIUM SILICATE | ORAL | TABLET, COATED | 1343880 | 9B9691B2N9 | 29.03mg | ||
| MAGNESIUM SILICATE | ORAL | TABLET, DELAYED RELEASE | 1343880 | 9B9691B2N9 | 180mg | ||
| MAGNESIUM SILICATE | ORAL | TABLET, FILM COATED | 1343880 | 9B9691B2N9 | 33.7mg | ||
| MAGNESIUM SILICATE | ORAL | WAFER | 1343880 | 9B9691B2N9 | 22mg | ||
| MAGNESIUM SILICATE | SUBLINGUAL | TABLET | 1343880 | 9B9691B2N9 | 1.2mg | ||
| MAGNESIUM SILICATE | TOPICAL | SOAP | 1343880 | 9B9691B2N9 | 0.33%w/w | ||
| MAGNESIUM STEARATE | BUCCAL | TABLET | 557040 | 70097M6I30 | 17.5mg | ||
| MAGNESIUM STEARATE | INTRAVITREAL | IMPLANT | 557040 | 70097M6I30 | NA | ||
| MAGNESIUM STEARATE | INTRAVITREAL | SYSTEM | 557040 | 70097M6I30 | 0.02mg | ||
| MAGNESIUM STEARATE | ORAL | CAPSULE | 557040 | 70097M6I30 | 256.4mg | ||
| MAGNESIUM STEARATE | ORAL | CAPSULE, COATED PELLETS | 557040 | 70097M6I30 | 0.15mg | ||
| MAGNESIUM STEARATE | ORAL | CAPSULE, COATED, EXTENDED RELEASE | 557040 | 70097M6I30 | NA | ||
| MAGNESIUM STEARATE | ORAL | CAPSULE, DELAYED RELEASE | 557040 | 70097M6I30 | 325mg | ||
| MAGNESIUM STEARATE | ORAL | CAPSULE, EXTENDED RELEASE | 557040 | 70097M6I30 | 117mg | ||
| MAGNESIUM STEARATE | ORAL | CAPSULE, GELATIN COATED | 557040 | 70097M6I30 | 2mg | ||
| MAGNESIUM STEARATE | ORAL | DROPS | 557040 | 70097M6I30 | NA | ||
| MAGNESIUM STEARATE | ORAL | GRANULE | 557040 | 70097M6I30 | 629mg | ||
| MAGNESIUM STEARATE | ORAL | GRANULE, FOR SUSPENSION | 557040 | 70097M6I30 | 14mg | ||
| MAGNESIUM STEARATE | ORAL | INHALANT | 557040 | 70097M6I30 | 0.08mg | ||
| MAGNESIUM STEARATE | ORAL | LOZENGE | 557040 | 70097M6I30 | 420mg | ||
| MAGNESIUM STEARATE | ORAL | PELLET | 557040 | 70097M6I30 | 24mg | ||
| MAGNESIUM STEARATE | ORAL | POWDER | 557040 | 70097M6I30 | 25mg | ||
| MAGNESIUM STEARATE | ORAL | POWDER, FOR SUSPENSION | 557040 | 70097M6I30 | 32.5mg/5ml | ||
| MAGNESIUM STEARATE | ORAL | SUSPENSION | 557040 | 70097M6I30 | 57.56mg/5ml | ||
| MAGNESIUM STEARATE | ORAL | SUSPENSION, EXTENDED RELEASE | 557040 | 70097M6I30 | 71mg | ||
| MAGNESIUM STEARATE | ORAL | TABLET | 557040 | 70097M6I30 | 980mg | ||
| MAGNESIUM STEARATE | ORAL | TABLET, CHEWABLE | 557040 | 70097M6I30 | 127mg | ||
| MAGNESIUM STEARATE | ORAL | TABLET, CHEWABLE, EXTENDED RELEASE | 557040 | 70097M6I30 | 9mg | ||
| MAGNESIUM STEARATE | ORAL | TABLET, COATED | 557040 | 70097M6I30 | 184mg | ||
| MAGNESIUM STEARATE | ORAL | TABLET, DELAYED RELEASE | 557040 | 70097M6I30 | 144mg | ||
| MAGNESIUM STEARATE | ORAL | TABLET, EXTENDED RELEASE | 557040 | 70097M6I30 | 173mg | ||
| MAGNESIUM STEARATE | ORAL | TABLET, FILM COATED | 557040 | 70097M6I30 | 96mg | ||
| MAGNESIUM STEARATE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 557040 | 70097M6I30 | 35mg | ||
| MAGNESIUM STEARATE | ORAL | TABLET, FOR SUSPENSION | 557040 | 70097M6I30 | 131mg | ||
| MAGNESIUM STEARATE | ORAL | TABLET, MULTILAYER, EXTENDED RELEASE | 557040 | 70097M6I30 | 30mg | ||
| MAGNESIUM STEARATE | ORAL | TABLET, ORALLY DISINTEGRATING | 557040 | 70097M6I30 | 187mg | ||
| MAGNESIUM STEARATE | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 557040 | 70097M6I30 | 47mg | ||
| MAGNESIUM STEARATE | ORAL | TABLET, SUGAR COATED | 557040 | 70097M6I30 | NA | ||
| MAGNESIUM STEARATE | ORAL | TROCHE | 557040 | 70097M6I30 | 315mg | ||
| MAGNESIUM STEARATE | ORAL | WAFER | 557040 | 70097M6I30 | 66mg | ||
| MAGNESIUM STEARATE | RESPIRATORY (INHALATION) | POWDER | 557040 | 70097M6I30 | 0.13mg | ||
| MAGNESIUM STEARATE | SUBCUTANEOUS | IMPLANT | 557040 | 70097M6I30 | 0.5mg | ||
| MAGNESIUM STEARATE | SUBLINGUAL | TABLET | 557040 | 70097M6I30 | 17.5mg | ||
| MAGNESIUM STEARATE | TOPICAL | CREAM | 557040 | 70097M6I30 | NA | ||
| MAGNESIUM STEARATE | TOPICAL | POWDER | 557040 | 70097M6I30 | 104mg | ||
| MAGNESIUM STEARATE | TRANSMUCOSAL | LOZENGE | 557040 | 70097M6I30 | 25mg | ||
| MAGNESIUM STEARATE | VAGINAL | INSERT | 557040 | 70097M6I30 | 69mg | ||
| MAGNESIUM STEARATE | VAGINAL | RING | 557040 | 70097M6I30 | 2mg | ||
| MAGNESIUM SULFATE | ORAL | CAPSULE | DE08037SAB | NA | |||
| MAGNESIUM SULFATE | ORAL | TABLET | DE08037SAB | 2.9mg | |||
| MAGNESIUM SULFATE | ORAL | TABLET, COATED | DE08037SAB | NA | |||
| MAGNESIUM SULFATE | ORAL | TABLET, EXTENDED RELEASE | DE08037SAB | 4mg | |||
| MAGNESIUM SULFATE | ORAL | TABLET, FILM COATED | DE08037SAB | 14mg | |||
| MAGNESIUM SULFATE | TOPICAL | SOAP | DE08037SAB | 0.2%w/w | |||
| MAGNESIUM SULFATE ANHYDROUS | ORAL | CAPSULE | 7487889 | ML30MJ2U7I | 29.8mg | ||
| MAGNESIUM TRISILICATE | ORAL | POWDER, FOR SUSPENSION | 39365872 | C2E1CI501T | 70mg | ||
| MAGNESIUM TRISILICATE | ORAL | TABLET | 39365872 | C2E1CI501T | 104mg | ||
| MAGNESIUM TRISILICATE | ORAL | TABLET, CHEWABLE | 39365872 | C2E1CI501T | 76.89mg | ||
| MAGNESIUM TRISILICATE | ORAL | TABLET, COATED | 39365872 | C2E1CI501T | 20mg | ||
| MAGNESIUM TRISILICATE | ORAL | TABLET, DELAYED RELEASE | 39365872 | C2E1CI501T | 120mg | ||
| MAGNESIUM TRISILICATE | ORAL | TABLET, EXTENDED RELEASE | 39365872 | C2E1CI501T | 225mg | ||
| MAGNESIUM TRISILICATE | ORAL | TABLET, FILM COATED | 39365872 | C2E1CI501T | 40mg | ||
| MALEIC ACID | INTRAMUSCULAR | INJECTION | 110167 | 91XW058U2C | 1mg | ||
| MALEIC ACID | INTRAVENOUS | INJECTION | 110167 | 91XW058U2C | 1mg | ||
| MALEIC ACID | ORAL | CAPSULE | 110167 | 91XW058U2C | 2mg | ||
| MALEIC ACID | ORAL | SYRUP | 110167 | 91XW058U2C | 1.73mg/5ml | ||
| MALEIC ACID | ORAL | TABLET | 110167 | 91XW058U2C | 4mg | ||
| MALIC ACID | ORAL | LIQUID | 6915157 | 817L1N4CKP | ADJ PH | ||
| MALIC ACID | ORAL | POWDER | 6915157 | 817L1N4CKP | 232mg | ||
| MALIC ACID | ORAL | POWDER, FOR SOLUTION | 6915157 | 817L1N4CKP | 1230mg | ||
| MALIC ACID | ORAL | SOLUTION | 6915157 | 817L1N4CKP | 16760mg | ||
| MALIC ACID | ORAL | SUSPENSION | 6915157 | 817L1N4CKP | 180mg | ||
| MALIC ACID | ORAL | TABLET | 6915157 | 817L1N4CKP | 20mg | Y | |
| MALIC ACID, L- | ORAL | SOLUTION | 97676 | J3TZF807X5 | 34mg/10ml | ||
| MALIC ACID, L- | ORAL | TABLET | 97676 | J3TZF807X5 | NA | ||
| MALTITOL | BUCCAL | GUM, CHEWING | 585886 | D65DG142WK | 4932mg | ||
| MALTITOL | ORAL | CAPSULE | 585886 | D65DG142WK | 155mg | ||
| MALTITOL | ORAL | FILM, SOLUBLE | 585886 | D65DG142WK | 44mg | ||
| MALTITOL | ORAL | LIQUID | 585886 | D65DG142WK | 3420mg | ||
| MALTITOL | ORAL | SOLUTION | 585886 | D65DG142WK | 9000mg | ||
| MALTITOL | ORAL | SUSPENSION | 585886 | D65DG142WK | 39600mg/120ml | ||
| MALTITOL | ORAL | SYRUP | 585886 | D65DG142WK | 5000mg | ||
| MALTITOL | ORAL | TABLET, ORALLY DISINTEGRATING | 585886 | D65DG142WK | 1mg | ||
| MALTITOL | SUBLINGUAL | FILM | 585886 | D65DG142WK | 24mg | ||
| MALTODEXTRIN | ORAL | CAPSULE | 9050366 | 7CVR7L4A2D | 200mg | ||
| MALTODEXTRIN | ORAL | FILM, SOLUBLE | 9050366 | 7CVR7L4A2D | 3.2mg | ||
| MALTODEXTRIN | ORAL | GRANULE, FOR SUSPENSION | 9050366 | 7CVR7L4A2D | 952mg | ||
| MALTODEXTRIN | ORAL | LOZENGE | 9050366 | 7CVR7L4A2D | 175mg | ||
| MALTODEXTRIN | ORAL | PASTE | 9050366 | 7CVR7L4A2D | 1050mg | ||
| MALTODEXTRIN | ORAL | POWDER, FOR SUSPENSION | 9050366 | 7CVR7L4A2D | 8000mg | ||
| MALTODEXTRIN | ORAL | SOLUTION | 9050366 | 7CVR7L4A2D | 1451mg | ||
| MALTODEXTRIN | ORAL | SUSPENSION | 9050366 | 7CVR7L4A2D | 2550mg | ||
| MALTODEXTRIN | ORAL | TABLET | 9050366 | 7CVR7L4A2D | 80mg | ||
| MALTODEXTRIN | ORAL | TABLET, CHEWABLE | 9050366 | 7CVR7L4A2D | 292mg | ||
| MALTODEXTRIN | ORAL | TABLET, COATED | 9050366 | 7CVR7L4A2D | 5.6mg | ||
| MALTODEXTRIN | ORAL | TABLET, EFFERVESCENT | 9050366 | 7CVR7L4A2D | 14404mg | ||
| MALTODEXTRIN | ORAL | TABLET, EXTENDED RELEASE | 9050366 | 7CVR7L4A2D | 3239mg | ||
| MALTODEXTRIN | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9050366 | 7CVR7L4A2D | NA | ||
| MALTODEXTRIN | ORAL | TABLET, ORALLY DISINTEGRATING | 9050366 | 7CVR7L4A2D | 12mg | ||
| MALTOL | ORAL | CONCENTRATE | 118718 | 3A9RD92BS4 | 0.1mg/1ml | ||
| MALTOL | ORAL | SOLUTION | 118718 | 3A9RD92BS4 | 0.1mg | ||
| MALTOSE ANHYDROUS | ORAL | TABLET | 69794 | 66Y63L379N | 2838mg | ||
| MALTOSE MONOHYDRATE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 6363537 | DM477EE40D | 300mg | ||
| MALTOSE MONOHYDRATE | ORAL | TABLET | 6363537 | DM477EE40D | 2283mg | ||
| MANNITOL | BUCCAL | GUM, CHEWING | 69658 | 3OWL53L36A | 891mg | ||
| MANNITOL | BUCCAL | TABLET | 69658 | 3OWL53L36A | 180.19mg | ||
| MANNITOL | INTRAMUSCULAR | INJECTION | 69658 | 3OWL53L36A | 106.6mg | ||
| MANNITOL | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 69658 | 3OWL53L36A | 300mg | ||
| MANNITOL | INTRAMUSCULAR | INJECTION, POWDER, FOR SUSPENSION | 69658 | 3OWL53L36A | 94mg | ||
| MANNITOL | INTRAMUSCULAR | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 69658 | 3OWL53L36A | 113mg | ||
| MANNITOL | INTRAMUSCULAR | INJECTION, SUSPENSION | 69658 | 3OWL53L36A | 71mg | ||
| MANNITOL | INTRAMUSCULAR | INJECTION, SUSPENSION, EXTENDED RELEASE | 69658 | 3OWL53L36A | 105mg | ||
| MANNITOL | INTRAMUSCULAR | POWDER, FOR SUSPENSION | 69658 | 3OWL53L36A | 6.75%w/v | ||
| MANNITOL | INTRAVENOUS | CONCENTRATE | 69658 | 3OWL53L36A | 220mg | ||
| MANNITOL | INTRAVENOUS | INJECTION | 69658 | 3OWL53L36A | 15200mg | ||
| MANNITOL | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 69658 | 3OWL53L36A | 980.4mg | ||
| MANNITOL | INTRAVENOUS | INJECTION, POWDER, FOR SUSPENSION | 69658 | 3OWL53L36A | 181mg | ||
| MANNITOL | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 69658 | 3OWL53L36A | 15400mg | ||
| MANNITOL | INTRAVENOUS | INJECTION, SOLUTION | 69658 | 3OWL53L36A | 15400mg | ||
| MANNITOL | INTRAVENOUS | INJECTION, SUSPENSION | 69658 | 3OWL53L36A | 2.5%w/v | ||
| MANNITOL | INTRAVENOUS | SOLUTION | 69658 | 3OWL53L36A | 15400mg | ||
| MANNITOL | INTRAVENOUS | SOLUTION, CONCENTRATE | 69658 | 3OWL53L36A | 4.4%w/v | ||
| MANNITOL | NASAL | SPRAY | 69658 | 3OWL53L36A | 41.5mg | ||
| MANNITOL | OPHTHALMIC | GEL | 69658 | 3OWL53L36A | 5%w/w | ||
| MANNITOL | OPHTHALMIC | SOLUTION | 69658 | 3OWL53L36A | 4.7%w/v | ||
| MANNITOL | OPHTHALMIC | SOLUTION, GEL FORMING, EXTENDED RELEASE | 69658 | 3OWL53L36A | 4.35%w/w | ||
| MANNITOL | OPHTHALMIC | SOLUTION/ DROPS | 69658 | 3OWL53L36A | 4.6%w/v | ||
| MANNITOL | OPHTHALMIC | SUSPENSION | 69658 | 3OWL53L36A | 6mg | ||
| MANNITOL | OPHTHALMIC | SUSPENSION/ DROPS | 69658 | 3OWL53L36A | 3.3%w/v | ||
| MANNITOL | ORAL | CAPSULE | 69658 | 3OWL53L36A | 1562mg | ||
| MANNITOL | ORAL | CAPSULE, COATED PELLETS | 69658 | 3OWL53L36A | 14mg | ||
| MANNITOL | ORAL | CAPSULE, COATED, EXTENDED RELEASE | 69658 | 3OWL53L36A | NA | ||
| MANNITOL | ORAL | CAPSULE, DELAYED RELEASE | 69658 | 3OWL53L36A | 2043mg | ||
| MANNITOL | ORAL | CAPSULE, EXTENDED RELEASE | 69658 | 3OWL53L36A | 160mg | ||
| MANNITOL | ORAL | GRANULE | 69658 | 3OWL53L36A | 1328mg | ||
| MANNITOL | ORAL | GRANULE, FOR SUSPENSION | 69658 | 3OWL53L36A | 6000mg | ||
| MANNITOL | ORAL | LOZENGE | 69658 | 3OWL53L36A | 20546mg | ||
| MANNITOL | ORAL | POWDER | 69658 | 3OWL53L36A | 4352mg | ||
| MANNITOL | ORAL | POWDER, FOR SOLUTION | 69658 | 3OWL53L36A | 3767mg | ||
| MANNITOL | ORAL | POWDER, FOR SUSPENSION | 69658 | 3OWL53L36A | 6600mg | ||
| MANNITOL | ORAL | SOLUTION | 69658 | 3OWL53L36A | 869mg | ||
| MANNITOL | ORAL | SUSPENSION | 69658 | 3OWL53L36A | 2401mg | ||
| MANNITOL | ORAL | SUSPENSION, EXTENDED RELEASE | 69658 | 3OWL53L36A | 2464.6mg | ||
| MANNITOL | ORAL | TABLET | 69658 | 3OWL53L36A | 3391mg | ||
| MANNITOL | ORAL | TABLET, CHEWABLE | 69658 | 3OWL53L36A | 3726mg | ||
| MANNITOL | ORAL | TABLET, CHEWABLE, EXTENDED RELEASE | 69658 | 3OWL53L36A | 616mg | ||
| MANNITOL | ORAL | TABLET, COATED | 69658 | 3OWL53L36A | 177.7mg | ||
| MANNITOL | ORAL | TABLET, DELAYED RELEASE | 69658 | 3OWL53L36A | 639mg | ||
| MANNITOL | ORAL | TABLET, EXTENDED RELEASE | 69658 | 3OWL53L36A | 436mg | ||
| MANNITOL | ORAL | TABLET, FILM COATED | 69658 | 3OWL53L36A | 2309mg | ||
| MANNITOL | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 69658 | 3OWL53L36A | 543mg | ||
| MANNITOL | ORAL | TABLET, FOR SUSPENSION | 69658 | 3OWL53L36A | 7621mg | ||
| MANNITOL | ORAL | TABLET, ORALLY DISINTEGRATING | 69658 | 3OWL53L36A | 4364mg | ||
| MANNITOL | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 69658 | 3OWL53L36A | 1568mg | ||
| MANNITOL | ORAL | TROCHE | 69658 | 3OWL53L36A | 14594mg | ||
| MANNITOL | ORAL | WAFER | 69658 | 3OWL53L36A | 642mg | ||
| MANNITOL | PARENTERAL | INJECTION | 69658 | 3OWL53L36A | 4.4%w/v | ||
| MANNITOL | PARENTERAL | INJECTION, POWDER, FOR SOLUTION | 69658 | 3OWL53L36A | 200mg | ||
| MANNITOL | PARENTERAL | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 69658 | 3OWL53L36A | 7.5%w/v | ||
| MANNITOL | RESPIRATORY (INHALATION) | POWDER | 69658 | 3OWL53L36A | 6mg | ||
| MANNITOL | SUBCUTANEOUS | INJECTION | 69658 | 3OWL53L36A | 180mg | ||
| MANNITOL | SUBCUTANEOUS | INJECTION, POWDER, FOR SOLUTION | 69658 | 3OWL53L36A | 35mg | ||
| MANNITOL | SUBCUTANEOUS | INJECTION, POWDER, FOR SUSPENSION | 69658 | 3OWL53L36A | 180mg | ||
| MANNITOL | SUBCUTANEOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 69658 | 3OWL53L36A | 658mg | ||
| MANNITOL | SUBCUTANEOUS | INJECTION, SOLUTION | 69658 | 3OWL53L36A | 99mg | ||
| MANNITOL | SUBCUTANEOUS | SOLUTION | 69658 | 3OWL53L36A | 1.59%w/v | ||
| MANNITOL | SUBLINGUAL | TABLET | 69658 | 3OWL53L36A | 495mg | ||
| MANNITOL | SUBLINGUAL | TABLET, ORALLY DISINTEGRATING | 69658 | 3OWL53L36A | 10.25mg | ||
| MANNITOL | SUBMUCOSAL | INJECTION, SOLUTION | 69658 | 3OWL53L36A | 2.94%w/v | ||
| MANNITOL | TOPICAL | SOLUTION | 69658 | 3OWL53L36A | 5mg | ||
| MANNITOL | TOPICAL | SUSPENSION/ DROPS | 69658 | 3OWL53L36A | 0.3%w/v | ||
| MEDICAL ANTIFOAM EMULSION C | ORAL | SUSPENSION | NA | 0.17mg/5ml | |||
| MEDICAL ANTIFOAM EMULSION C | ORAL | TABLET | NA | 1mg | |||
| MEDICAL ANTIFOAM EMULSION C | ORAL | TABLET, EFFERVESCENT | NA | 0.05mg | |||
| MEDICAL ANTIFORM A-F EMULSION | TOPICAL | CREAM | NA | 0.1%w/w | |||
| MEDIUM-CHAIN TRIGLYCERIDES | INTRAVENOUS | INJECTION, EMULSION | 438544491 | C9H2L21V7U | 1.1%w/v | ||
| MEDIUM-CHAIN TRIGLYCERIDES | ORAL | CAPSULE | 438544491 | C9H2L21V7U | 4771mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | ORAL | CAPSULE, LIQUID FILLED | 438544491 | C9H2L21V7U | 866mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | ORAL | POWDER, FOR SUSPENSION | 438544491 | C9H2L21V7U | 3390mg/5ml | ||
| MEDIUM-CHAIN TRIGLYCERIDES | ORAL | SOLUTION | 438544491 | C9H2L21V7U | 1899mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | ORAL | SUSPENSION | 438544491 | C9H2L21V7U | 10170mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | ORAL | TABLET | 438544491 | C9H2L21V7U | 2mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | ORAL | TABLET, EXTENDED RELEASE | 438544491 | C9H2L21V7U | 0.37mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | ORAL | TABLET, ORALLY DISINTEGRATING | 438544491 | C9H2L21V7U | 1mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | SUBCUTANEOUS | INJECTION, SUSPENSION, EXTENDED RELEASE | 438544491 | C9H2L21V7U | 990.3mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | SUBLINGUAL | POWDER | 438544491 | C9H2L21V7U | 2mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | SUBLINGUAL | SPRAY, METERED | 438544491 | C9H2L21V7U | 110mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | TOPICAL | AEROSOL, FOAM | 438544491 | C9H2L21V7U | 10.87%w/w | ||
| MEDIUM-CHAIN TRIGLYCERIDES | TOPICAL | CREAM | 438544491 | C9H2L21V7U | 570mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | TOPICAL | CREAM, AUGMENTED | 438544491 | C9H2L21V7U | 8%w/w | ||
| MEDIUM-CHAIN TRIGLYCERIDES | TOPICAL | GEL | 438544491 | C9H2L21V7U | 12mg | Y | |
| MEDIUM-CHAIN TRIGLYCERIDES | TOPICAL | LOTION | 438544491 | C9H2L21V7U | 7%w/w | ||
| MEDIUM-CHAIN TRIGLYCERIDES | TOPICAL | OINTMENT | 438544491 | C9H2L21V7U | 20%w/w | ||
| MEDIUM-CHAIN TRIGLYCERIDES | TOPICAL | SPRAY | 438544491 | C9H2L21V7U | 540mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | TRANSDERMAL | FILM, EXTENDED RELEASE | 438544491 | C9H2L21V7U | NA | ||
| MEGLUMINE | INTRAMUSCULAR | INJECTION | 6284408 | 6HG8UB2MUY | 144.76mg | ||
| MEGLUMINE | INTRAVASCULAR | INJECTION | 6284408 | 6HG8UB2MUY | ADJ PH | ||
| MEGLUMINE | INTRAVENOUS | INJECTION | 6284408 | 6HG8UB2MUY | 154mg | ||
| MEGLUMINE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 6284408 | 6HG8UB2MUY | 75mg | ||
| MEGLUMINE | ORAL | CAPSULE, COATED, EXTENDED RELEASE | 6284408 | 6HG8UB2MUY | NA | ||
| MEGLUMINE | ORAL | CAPSULE, DELAYED RELEASE | 6284408 | 6HG8UB2MUY | 21mg | ||
| MEGLUMINE | ORAL | CAPSULE, EXTENDED RELEASE | 6284408 | 6HG8UB2MUY | 4mg | ||
| MEGLUMINE | ORAL | TABLET | 6284408 | 6HG8UB2MUY | 25mg | ||
| MEGLUMINE | ORAL | TABLET, DELAYED RELEASE | 6284408 | 6HG8UB2MUY | 10mg | ||
| MEGLUMINE | ORAL | TABLET, FILM COATED | 6284408 | 6HG8UB2MUY | 24mg | ||
| MENTHOL | BUCCAL | GUM, CHEWING | L7T10EIP3A | 89mg | |||
| MENTHOL | BUCCAL | MOUTHWASH | L7T10EIP3A | 0.15mg/1ml | |||
| MENTHOL | DENTAL | PASTE, DENTIFRICE | L7T10EIP3A | 4.7%w/w | |||
| MENTHOL | DENTAL | SOLUTION | L7T10EIP3A | NA | |||
| MENTHOL | NASAL | DROPS | L7T10EIP3A | 40.32mg | |||
| MENTHOL | NASAL | INHALANT | L7T10EIP3A | 32mg | |||
| MENTHOL | NASAL | JELLY | L7T10EIP3A | 32.5mg | |||
| MENTHOL | OPHTHALMIC | DROPS | L7T10EIP3A | NA | |||
| MENTHOL | ORAL | CAPSULE | L7T10EIP3A | 0.87mg | |||
| MENTHOL | ORAL | CONCENTRATE | L7T10EIP3A | 0.05mg/5ml | |||
| MENTHOL | ORAL | LOZENGE | L7T10EIP3A | 23mg | |||
| MENTHOL | ORAL | POWDER, FOR SOLUTION | L7T10EIP3A | NA | |||
| MENTHOL | ORAL | SOLUTION | L7T10EIP3A | 0.5mg/1ml | |||
| MENTHOL | ORAL | SOLUTION, CONCENTRATE | L7T10EIP3A | 0.5mg/1ml | |||
| MENTHOL | ORAL | SUSPENSION | L7T10EIP3A | 1mg | |||
| MENTHOL | ORAL | SYRUP | L7T10EIP3A | 7.5mg/5ml | |||
| MENTHOL | ORAL | TABLET | L7T10EIP3A | 0.58mg | |||
| MENTHOL | ORAL | TABLET, ORALLY DISINTEGRATING | L7T10EIP3A | 14mg | |||
| MENTHOL | RESPIRATORY (INHALATION) | AEROSOL, METERED | L7T10EIP3A | 0.02%w/w | |||
| MENTHOL | RESPIRATORY (INHALATION) | AEROSOL, SPRAY | L7T10EIP3A | 0.02%w/w | |||
| MENTHOL | SUBLINGUAL | TABLET | L7T10EIP3A | 2mg | |||
| MENTHOL | TOPICAL | CREAM | L7T10EIP3A | 0.1%w/w | |||
| MENTHOL | TOPICAL | GEL | L7T10EIP3A | 0.1%w/w | |||
| MENTHOL | TOPICAL | LOTION | L7T10EIP3A | 0.05%w/w | |||
| MENTHOL | TOPICAL | SOAP | L7T10EIP3A | 0.75%w/w | |||
| MENTHOL | TOPICAL | SOLUTION | L7T10EIP3A | 0.08%w/v | |||
| METACRESOL | INTRADERMAL | INJECTION | 108394 | GGO4Y809LO | 0.16%w/v | ||
| METACRESOL | INTRAMUSCULAR | INJECTION | 108394 | GGO4Y809LO | 0.1%w/v | ||
| METACRESOL | INTRAVENOUS | INJECTION | 108394 | GGO4Y809LO | 0.3%w/v | ||
| METACRESOL | SUBCUTANEOUS | INJECTION | 108394 | GGO4Y809LO | 0.3%w/v | ||
| METACRESOL | SUBCUTANEOUS | INJECTION, SOLUTION | 108394 | GGO4Y809LO | 0.22%w/v | ||
| METACRESOL | SUBCUTANEOUS | INJECTION, SUSPENSION | 108394 | GGO4Y809LO | 0.16%w/v | ||
| METACRESOL | SUBCUTANEOUS | SOLUTION | 108394 | GGO4Y809LO | 0.1%w/v | ||
| METANIL YELLOW | ORAL | TABLET | 587984 | 7SPF5O5BW8 | NA | ||
| METANIL YELLOW | TOPICAL | SOAP | 587984 | 7SPF5O5BW8 | 0.01%w/w | ||
| METAPHOSPHORIC ACID | INTRAVENOUS | INJECTION | 37267860 | MTK99R3UV0 | 0.13%w/v | ||
| METAPHOSPHORIC ACID | ORAL | CAPSULE | 37267860 | MTK99R3UV0 | NA | ||
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | ORAL | CAPSULE | 25212888 | NX76LV5T8J | 323mg | ||
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | ORAL | CAPSULE, COATED | 25212888 | NX76LV5T8J | 56mg | ||
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | ORAL | CAPSULE, COATED PELLETS | 25212888 | NX76LV5T8J | 32mg | ||
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | ORAL | CAPSULE, DELAYED RELEASE | 25212888 | NX76LV5T8J | 1321mg | ||
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | ORAL | CAPSULE, DELAYED RELEASE PELLETS | 25212888 | NX76LV5T8J | 549mg | ||
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | ORAL | CAPSULE, EXTENDED RELEASE | 25212888 | NX76LV5T8J | 283mg | ||
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | ORAL | GRANULE, FOR SUSPENSION | 25212888 | NX76LV5T8J | 1250mg | ||
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | ORAL | TABLET | 25212888 | NX76LV5T8J | 489mg | ||
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | ORAL | TABLET, DELAYED RELEASE | 25212888 | NX76LV5T8J | 1500mg | ||
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | ORAL | TABLET, EXTENDED RELEASE | 25212888 | NX76LV5T8J | 400mg | ||
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 25212888 | NX76LV5T8J | 15mg | ||
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | ORAL | TABLET, ORALLY DISINTEGRATING | 25212888 | NX76LV5T8J | 20mg | ||
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 25212888 | NX76LV5T8J | 570mg | ||
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) | ORAL | CAPSULE | 25086151 | 74G4R6TH13 | 58mg | ||
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) | ORAL | CAPSULE, COATED PELLETS | 25086151 | 74G4R6TH13 | 93.36mg | ||
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) | ORAL | CAPSULE, DELAYED RELEASE | 25086151 | 74G4R6TH13 | 79mg | ||
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) | ORAL | CAPSULE, EXTENDED RELEASE | 25086151 | 74G4R6TH13 | 225mg | ||
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) | ORAL | SUSPENSION | 25086151 | 74G4R6TH13 | NA | ||
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) | ORAL | TABLET | 25086151 | 74G4R6TH13 | 13.65mg | ||
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) | ORAL | TABLET, DELAYED RELEASE | 25086151 | 74G4R6TH13 | 172mg | ||
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) | ORAL | TABLET, EXTENDED RELEASE | 25086151 | 74G4R6TH13 | 109mg | ||
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 25086151 | 74G4R6TH13 | 10.08mg | ||
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) | ORAL | TABLET, ORALLY DISINTEGRATING | 25086151 | 74G4R6TH13 | 46mg | ||
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | ORAL | CAPSULE | 25086151 | 5KY68S2577 | 116.1mg | ||
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | ORAL | CAPSULE, DELAYED RELEASE | 25086151 | 5KY68S2577 | 107mg | ||
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | ORAL | CAPSULE, EXTENDED RELEASE | 25086151 | 5KY68S2577 | 301mg | ||
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | ORAL | TABLET | 25086151 | 5KY68S2577 | 92mg | ||
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | ORAL | TABLET, DELAYED RELEASE | 25086151 | 5KY68S2577 | 245mg | ||
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | ORAL | TABLET, EXTENDED RELEASE | 25086151 | 5KY68S2577 | 211mg | ||
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 25086151 | 5KY68S2577 | 4.32mg | ||
| METHACRYLIC ACID COPOLYMER | ORAL | CAPSULE | NA | 154mg | |||
| METHACRYLIC ACID COPOLYMER | ORAL | CAPSULE, COATED | NA | 56mg | |||
| METHACRYLIC ACID COPOLYMER | ORAL | CAPSULE, COATED PELLETS | NA | 44.6mg | |||
| METHACRYLIC ACID COPOLYMER | ORAL | CAPSULE, COATED, EXTENDED RELEASE | NA | NA | |||
| METHACRYLIC ACID COPOLYMER | ORAL | CAPSULE, DELAYED RELEASE | NA | 684mg | |||
| METHACRYLIC ACID COPOLYMER | ORAL | CAPSULE, EXTENDED RELEASE | NA | 121mg | |||
| METHACRYLIC ACID COPOLYMER | ORAL | GRANULE, DELAYED RELEASE | NA | 430.8mg | |||
| METHACRYLIC ACID COPOLYMER | ORAL | GRANULE, FOR SUSPENSION | NA | 69.48mg | |||
| METHACRYLIC ACID COPOLYMER | ORAL | TABLET | NA | 109mg | |||
| METHACRYLIC ACID COPOLYMER | ORAL | TABLET, DELAYED RELEASE | NA | 347mg | |||
| METHACRYLIC ACID COPOLYMER | ORAL | TABLET, EXTENDED RELEASE | NA | 99mg | |||
| METHACRYLIC ACID COPOLYMER | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | NA | 24.6mg | |||
| METHANESULFONIC ACID | INTRAMUSCULAR | INJECTION | 75752 | 12EH9M7279 | ADJ PH | ||
| METHANESULFONIC ACID | INTRAMUSCULAR | INJECTION, SOLUTION | 75752 | 12EH9M7279 | ADJ PH | ||
| METHANESULFONIC ACID | INTRAVENOUS | INJECTION | 75752 | 12EH9M7279 | ADJ PH | ||
| METHANESULFONIC ACID | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 75752 | 12EH9M7279 | 80.7mg | ||
| METHANESULFONIC ACID | INTRAVENOUS | INJECTION, SOLUTION | 75752 | 12EH9M7279 | ADJ PH | ||
| METHANESULFONIC ACID | SUBCUTANEOUS | INJECTION | 75752 | 12EH9M7279 | ADJ PH | ||
| METHANESULFONIC ACID | SUBCUTANEOUS | INJECTION, SOLUTION | 75752 | 12EH9M7279 | ADJ PH | ||
| METHIONINE | INTRATHECAL | INJECTION | 63683 | AE28F7PNPL | 0.01%w/v | ||
| METHIONINE | INTRAVENOUS | INJECTION | 63683 | AE28F7PNPL | 16mg | ||
| METHIONINE | INTRAVENOUS | INJECTION, SOLUTION | 63683 | AE28F7PNPL | 0.16%w/v | ||
| METHIONINE | ORAL | TABLET | 63683 | AE28F7PNPL | NA | ||
| METHIONINE | SUBCUTANEOUS | INJECTION | 63683 | AE28F7PNPL | 0.15%w/v | ||
| METHIONINE | SUBCUTANEOUS | INJECTION, SUSPENSION | 63683 | AE28F7PNPL | 0.15%w/v | ||
| METHIONINE | SUBCUTANEOUS | SUSPENSION | 63683 | AE28F7PNPL | 0.15%w/v | ||
| METHYL ACRYLATE - METHYL METHACRYLATE | ORAL | TABLET, EXTENDED RELEASE | NA | NA | |||
| METHYL CHLORIDE | ORAL | TABLET | 74873 | A6R43525YO | 69.82mg | ||
| METHYL ETHYL KETONE | ORAL | TABLET, DELAYED RELEASE | 78933 | 6PT9KLV9IO | 61mg | ||
| METHYL GLUCETH-10 | TOPICAL | CREAM, AUGMENTED | 68239429 | N0MWT4C7WH | 5%w/w | ||
| METHYL GLUCETH-20 | TOPICAL | CREAM | 68239429 | J3QD0LD11P | 5%w/w | ||
| METHYL GLUCOSE SESQUISTEARATE | TOPICAL | CREAM | 68936958 | V1YW10H14D | 3.5%w/w | ||
| METHYL GLUCOSE SESQUISTEARATE | TOPICAL | CREAM, AUGMENTED | 68936958 | V1YW10H14D | 70mg | ||
| METHYL LAURATE | TOPICAL | GEL | 111820 | 8IPS6BI6KW | 25mg | ||
| METHYL LAURATE | TRANSDERMAL | FILM, EXTENDED RELEASE | 111820 | 8IPS6BI6KW | 17.6mg | ||
| METHYL LAURATE | TRANSDERMAL | GEL | 111820 | 8IPS6BI6KW | 0.25%w/w | ||
| METHYL SALICYLATE | DENTAL | PASTE, DENTIFRICE | 119368 | LAV5U5022Y | 1.1%w/w | ||
| METHYL SALICYLATE | DENTAL | POWDER, DENTIFRICE | 119368 | LAV5U5022Y | NA | ||
| METHYL SALICYLATE | ORAL | CAPSULE | 119368 | LAV5U5022Y | 16mg | ||
| METHYL SALICYLATE | ORAL | LOZENGE | 119368 | LAV5U5022Y | 53mg | ||
| METHYL SALICYLATE | ORAL | TABLET | 119368 | LAV5U5022Y | 10mg | ||
| METHYL SALICYLATE | TOPICAL | GEL | 119368 | LAV5U5022Y | 0.05%w/w | ||
| METHYL SALICYLATE | TOPICAL | POWDER | 119368 | LAV5U5022Y | NA | ||
| METHYL SALICYLATE | VAGINAL | DOUCHE | 119368 | LAV5U5022Y | 0.05%w/w | ||
| METHYL STEARATE | TOPICAL | CREAM | 112618 | 8D4NXF3ZH7 | 1%w/w | ||
| METHYL STEARATE | VAGINAL | CREAM | 112618 | 8D4NXF3ZH7 | 1%w/w | ||
| METHYLCELLULOSE | BUCCAL | TABLET | 9004675 | Z944H5SN0H | 4mg | ||
| METHYLCELLULOSE | INTRA-ARTICULAR | INJECTION | 9004675 | Z944H5SN0H | 0.1%w/v | ||
| METHYLCELLULOSE | INTRAMUSCULAR | INJECTION | 9004675 | Z944H5SN0H | 0.1%w/v | ||
| METHYLCELLULOSE | NASAL | JELLY | 9004675 | Z944H5SN0H | NA | ||
| METHYLCELLULOSE | OPHTHALMIC | DROPS | 9004675 | Z944H5SN0H | 0.12%w/w | ||
| METHYLCELLULOSE | OPHTHALMIC | SOLUTION | 9004675 | Z944H5SN0H | 0.16%w/w | ||
| METHYLCELLULOSE | OPHTHALMIC | SOLUTION/ DROPS | 9004675 | Z944H5SN0H | 0.5%w/v | ||
| METHYLCELLULOSE | OPHTHALMIC | SUSPENSION | 9004675 | Z944H5SN0H | 0.05%w/w | ||
| METHYLCELLULOSE | ORAL | CAPSULE | 9004675 | Z944H5SN0H | 13.5mg | ||
| METHYLCELLULOSE | ORAL | CAPSULE, EXTENDED RELEASE | 9004675 | Z944H5SN0H | 4mg | ||
| METHYLCELLULOSE | ORAL | POWDER, FOR SUSPENSION | 9004675 | Z944H5SN0H | 59.5mg/5ml | ||
| METHYLCELLULOSE | ORAL | SUSPENSION | 9004675 | Z944H5SN0H | 1000mg/10ml | ||
| METHYLCELLULOSE | ORAL | SYRUP | 9004675 | Z944H5SN0H | NA | ||
| METHYLCELLULOSE | ORAL | TABLET | 9004675 | Z944H5SN0H | 816mg | ||
| METHYLCELLULOSE | ORAL | TABLET, CHEWABLE | 9004675 | Z944H5SN0H | 50mg | ||
| METHYLCELLULOSE | ORAL | TABLET, COATED | 9004675 | Z944H5SN0H | 138.3mg | ||
| METHYLCELLULOSE | ORAL | TABLET, DELAYED RELEASE | 9004675 | Z944H5SN0H | 101mg | ||
| METHYLCELLULOSE | ORAL | TABLET, EXTENDED RELEASE | 9004675 | Z944H5SN0H | 96mg | ||
| METHYLCELLULOSE | ORAL | TABLET, FILM COATED | 9004675 | Z944H5SN0H | 21mg | ||
| METHYLCELLULOSE | SUBLINGUAL | TABLET | 9004675 | Z944H5SN0H | 4mg | ||
| METHYLCELLULOSE | TOPICAL | AEROSOL, FOAM | 9004675 | Z944H5SN0H | 0.11%w/w | ||
| METHYLCELLULOSE | TOPICAL | CREAM | 9004675 | Z944H5SN0H | 1.3%w/w | ||
| METHYLCELLULOSE | TOPICAL | EMULSION | 9004675 | Z944H5SN0H | NA | ||
| METHYLCELLULOSE | TOPICAL | JELLY | 9004675 | Z944H5SN0H | NA | ||
| METHYLCELLULOSE | TOPICAL | LOTION | 9004675 | Z944H5SN0H | 1.5%w/w | ||
| METHYLCELLULOSE | TOPICAL | SPONGE | 9004675 | Z944H5SN0H | NA | ||
| METHYLCELLULOSE (15 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 9004675 | NPU9M2E6L8 | 93mg | ||
| METHYLCELLULOSE (15 MPA.S) | ORAL | POWDER, FOR SUSPENSION | 9004675 | NPU9M2E6L8 | 3mg | Y | |
| METHYLCELLULOSE (15 MPA.S) | ORAL | TABLET | 9004675 | NPU9M2E6L8 | 360mg | ||
| METHYLCELLULOSE (15 MPA.S) | ORAL | TABLET, DELAYED RELEASE | 9004675 | NPU9M2E6L8 | 5mg | ||
| METHYLCELLULOSE (15 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004675 | NPU9M2E6L8 | 384mg | ||
| METHYLCELLULOSE (15 MPA.S) | ORAL | TABLET, FILM COATED | 9004675 | NPU9M2E6L8 | 68mg | ||
| METHYLCELLULOSE (1500 MPA.S) | ORAL | TABLET | 9004675 | P0NTE48364 | 319mg | ||
| METHYLCELLULOSE (400 MPA.S) | ORAL | CAPSULE | 9004675 | O0GN6F9B2Y | 4mg | Y | |
| METHYLCELLULOSE (400 MPA.S) | ORAL | POWDER, FOR SUSPENSION | 9004675 | O0GN6F9B2Y | 3mg | Y | |
| METHYLCELLULOSE (400 MPA.S) | ORAL | TABLET | 9004675 | O0GN6F9B2Y | 33mg | ||
| METHYLCELLULOSE (4000 MPA.S) | ORAL | SUSPENSION | 9004675 | MRJ667KA5E | 100mg | ||
| METHYLCELLULOSE (4000 MPA.S) | TOPICAL | CREAM | 9004675 | MRJ667KA5E | 0.3%w/w | Y | |
| METHYLCHLOROISOTHIAZOLINONE | TOPICAL | CREAM | 26172554 | DEL7T5QRPN | NA | ||
| METHYLCHLOROISOTHIAZOLINONE | TOPICAL | LOTION | 26172554 | DEL7T5QRPN | NA | ||
| METHYLCHLOROISOTHIAZOLINONE/METHYLISOTHIAZOLINONE MIXTURE | TOPICAL | CREAM | 55965849 | 15O9QS218W | 0.05%w/w | ||
| METHYLENE BLUE | TOPICAL | SOLUTION | 7220793 | T42P99266K | 0.06%w/v | ||
| METHYLPARABEN | AURICULAR (OTIC) | DROPS | 99763 | A2I8C7HI9T | 0.01%w/w | ||
| METHYLPARABEN | AURICULAR (OTIC) | SUSPENSION | 99763 | A2I8C7HI9T | NA | ||
| METHYLPARABEN | BUCCAL | FILM | 99763 | A2I8C7HI9T | 1mg | ||
| METHYLPARABEN | BUCCAL | FILM, SOLUBLE | 99763 | A2I8C7HI9T | 3mg | ||
| METHYLPARABEN | DENTAL | PASTE, DENTIFRICE | 99763 | A2I8C7HI9T | 0.05%w/w | ||
| METHYLPARABEN | EPIDURAL | INJECTION | 99763 | A2I8C7HI9T | 1mg | ||
| METHYLPARABEN | EPIDURAL | INJECTION, SOLUTION | 99763 | A2I8C7HI9T | 5%w/v | ||
| METHYLPARABEN | INFILTRATION | INJECTION | 99763 | A2I8C7HI9T | 80mg | Y | |
| METHYLPARABEN | INTRA-ARTICULAR | INJECTION | 99763 | A2I8C7HI9T | 0.24%w/v | ||
| METHYLPARABEN | INTRADERMAL | INJECTION | 99763 | A2I8C7HI9T | 1mg | ||
| METHYLPARABEN | INTRALESIONAL | INJECTION | 99763 | A2I8C7HI9T | 0.15%w/v | ||
| METHYLPARABEN | INTRAMUSCULAR | INJECTION | 99763 | A2I8C7HI9T | 54mg | ||
| METHYLPARABEN | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 99763 | A2I8C7HI9T | 3.6mg | ||
| METHYLPARABEN | INTRAMUSCULAR | INJECTION, SOLUTION | 99763 | A2I8C7HI9T | 45mg | ||
| METHYLPARABEN | INTRAMUSCULAR | INJECTION, SUSPENSION | 99763 | A2I8C7HI9T | 0.14%w/v | ||
| METHYLPARABEN | INTRAMUSCULAR | SOLUTION | 99763 | A2I8C7HI9T | 0.13%w/v | ||
| METHYLPARABEN | INTRAVENOUS | INJECTION | 99763 | A2I8C7HI9T | 80mg | ||
| METHYLPARABEN | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 99763 | A2I8C7HI9T | 15mg | ||
| METHYLPARABEN | INTRAVENOUS | INJECTION, SOLUTION | 99763 | A2I8C7HI9T | 5%w/v | ||
| METHYLPARABEN | INTRAVENOUS | SOLUTION | 99763 | A2I8C7HI9T | 0.13%w/v | ||
| METHYLPARABEN | IONTOPHORESIS | SOLUTION | 99763 | A2I8C7HI9T | 0.1%w/v | ||
| METHYLPARABEN | IRRIGATION | SOLUTION | 99763 | A2I8C7HI9T | 2%w/v | ||
| METHYLPARABEN | NASAL | DROPS | 99763 | A2I8C7HI9T | 26mg | ||
| METHYLPARABEN | NASAL | JELLY | 99763 | A2I8C7HI9T | 250mg | ||
| METHYLPARABEN | NASAL | SOLUTION | 99763 | A2I8C7HI9T | 250mg | ||
| METHYLPARABEN | OPHTHALMIC | DROPS | 99763 | A2I8C7HI9T | 0.01%w/w | ||
| METHYLPARABEN | OPHTHALMIC | OINTMENT | 99763 | A2I8C7HI9T | 0.05%w/w | ||
| METHYLPARABEN | OPHTHALMIC | SOLUTION | 99763 | A2I8C7HI9T | 0.05%w/w | ||
| METHYLPARABEN | OPHTHALMIC | SOLUTION/ DROPS | 99763 | A2I8C7HI9T | 0.05%w/v | ||
| METHYLPARABEN | OPHTHALMIC | SUSPENSION/ DROPS | 99763 | A2I8C7HI9T | 0.05%w/w | ||
| METHYLPARABEN | ORAL | CAPSULE | 99763 | A2I8C7HI9T | 7mg | ||
| METHYLPARABEN | ORAL | CAPSULE, EXTENDED RELEASE | 99763 | A2I8C7HI9T | 0.86mg | ||
| METHYLPARABEN | ORAL | CONCENTRATE | 99763 | A2I8C7HI9T | 12mg | ||
| METHYLPARABEN | ORAL | DROPS | 99763 | A2I8C7HI9T | 1mg/1ml | ||
| METHYLPARABEN | ORAL | ELIXIR | 99763 | A2I8C7HI9T | 800mg | ||
| METHYLPARABEN | ORAL | GRANULE, FOR SUSPENSION | 99763 | A2I8C7HI9T | 8mg/5ml | ||
| METHYLPARABEN | ORAL | LIQUID | 99763 | A2I8C7HI9T | 162mg | ||
| METHYLPARABEN | ORAL | POWDER | 99763 | A2I8C7HI9T | NA | ||
| METHYLPARABEN | ORAL | POWDER, FOR SOLUTION | 99763 | A2I8C7HI9T | 32mg | ||
| METHYLPARABEN | ORAL | POWDER, FOR SUSPENSION | 99763 | A2I8C7HI9T | 75mg | Y | |
| METHYLPARABEN | ORAL | SOLUTION | 99763 | A2I8C7HI9T | 346mg | ||
| METHYLPARABEN | ORAL | SOLUTION, CONCENTRATE | 99763 | A2I8C7HI9T | 1mg/1ml | ||
| METHYLPARABEN | ORAL | SUSPENSION | 99763 | A2I8C7HI9T | 1000mg/5ml | ||
| METHYLPARABEN | ORAL | SUSPENSION, EXTENDED RELEASE | 99763 | A2I8C7HI9T | 40mg | ||
| METHYLPARABEN | ORAL | SYRUP | 99763 | A2I8C7HI9T | 60mg | ||
| METHYLPARABEN | ORAL | TABLET | 99763 | A2I8C7HI9T | 1.8mg | ||
| METHYLPARABEN | ORAL | TABLET, CHEWABLE | 99763 | A2I8C7HI9T | 1.28mg | ||
| METHYLPARABEN | ORAL | TABLET, COATED | 99763 | A2I8C7HI9T | 0.8mg | ||
| METHYLPARABEN | ORAL | TABLET, EXTENDED RELEASE | 99763 | A2I8C7HI9T | 0.17mg | ||
| METHYLPARABEN | ORAL | TABLET, FILM COATED | 99763 | A2I8C7HI9T | 0.23mg | ||
| METHYLPARABEN | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 99763 | A2I8C7HI9T | NA | ||
| METHYLPARABEN | PARENTERAL | INJECTION | 99763 | A2I8C7HI9T | 18mg | ||
| METHYLPARABEN | PARENTERAL | INJECTION, SOLUTION | 99763 | A2I8C7HI9T | 5%w/v | ||
| METHYLPARABEN | PERIDURAL | INJECTION | 99763 | A2I8C7HI9T | 1mg | ||
| METHYLPARABEN | PERINEURAL | INJECTION | 99763 | A2I8C7HI9T | 80mg | Y | |
| METHYLPARABEN | RECTAL | ENEMA | 99763 | A2I8C7HI9T | 0.18%w/v | ||
| METHYLPARABEN | RECTAL | SOLUTION | 99763 | A2I8C7HI9T | 0.13%w/v | ||
| METHYLPARABEN | RECTAL | SUSPENSION | 99763 | A2I8C7HI9T | 1808mg | ||
| METHYLPARABEN | RESPIRATORY (INHALATION) | SOLUTION | 99763 | A2I8C7HI9T | 0.03%w/w | ||
| METHYLPARABEN | SOFT TISSUE | INJECTION | 99763 | A2I8C7HI9T | 0.15%w/v | ||
| METHYLPARABEN | SUBCUTANEOUS | INJECTION | 99763 | A2I8C7HI9T | 22mg | Y | |
| METHYLPARABEN | SUBCUTANEOUS | INJECTION, SUSPENSION | 99763 | A2I8C7HI9T | 0.16%w/v | ||
| METHYLPARABEN | SUBCUTANEOUS | SUSPENSION | 99763 | A2I8C7HI9T | 0.16%w/v | ||
| METHYLPARABEN | TOPICAL | AEROSOL, FOAM | 99763 | A2I8C7HI9T | 0.16%w/w | ||
| METHYLPARABEN | TOPICAL | CREAM | 99763 | A2I8C7HI9T | 29mg | ||
| METHYLPARABEN | TOPICAL | CREAM, AUGMENTED | 99763 | A2I8C7HI9T | 2mg | ||
| METHYLPARABEN | TOPICAL | EMULSION | 99763 | A2I8C7HI9T | 0.2%w/w | ||
| METHYLPARABEN | TOPICAL | GEL | 99763 | A2I8C7HI9T | 12mg | ||
| METHYLPARABEN | TOPICAL | JELLY | 99763 | A2I8C7HI9T | 0.07%w/v | ||
| METHYLPARABEN | TOPICAL | LOTION | 99763 | A2I8C7HI9T | 351mg | Y | |
| METHYLPARABEN | TOPICAL | OINTMENT | 99763 | A2I8C7HI9T | 29mg | ||
| METHYLPARABEN | TOPICAL | SHAMPOO | 99763 | A2I8C7HI9T | 0.15%w/w | ||
| METHYLPARABEN | TOPICAL | SHAMPOO, SUSPENSION | 99763 | A2I8C7HI9T | 0.15%w/w | ||
| METHYLPARABEN | TOPICAL | SOLUTION | 99763 | A2I8C7HI9T | 8mg | ||
| METHYLPARABEN | TOPICAL | SPRAY | 99763 | A2I8C7HI9T | 0.2%w/w | ||
| METHYLPARABEN | TOPICAL | SUSPENSION | 99763 | A2I8C7HI9T | 0.3%w/w | ||
| METHYLPARABEN | TOPICAL | SYSTEM | 99763 | A2I8C7HI9T | 42mg | ||
| METHYLPARABEN | URETHRAL | JELLY | 99763 | A2I8C7HI9T | 0.07%w/v | ||
| METHYLPARABEN | VAGINAL | AEROSOL, FOAM | 99763 | A2I8C7HI9T | 0.1%w/w | ||
| METHYLPARABEN | VAGINAL | CREAM | 99763 | A2I8C7HI9T | 8mg | ||
| METHYLPARABEN | VAGINAL | GEL | 99763 | A2I8C7HI9T | 8mg | ||
| METHYLPARABEN | VAGINAL | SUPPOSITORY | 99763 | A2I8C7HI9T | NA | ||
| METHYLPARABEN SODIUM | ORAL | CAPSULE | 5026620 | CR6K9C2NHK | 2mg | ||
| METHYLPARABEN SODIUM | ORAL | POWDER, FOR SUSPENSION | 5026620 | CR6K9C2NHK | 80mg | ||
| METHYLPARABEN SODIUM | ORAL | SOLUTION | 5026620 | CR6K9C2NHK | 134mg | ||
| METHYLPARABEN SODIUM | ORAL | SUSPENSION | 5026620 | CR6K9C2NHK | 36mg | ||
| METHYLPARABEN SODIUM | ORAL | TABLET | 5026620 | CR6K9C2NHK | 0.19mg | ||
| METHYLPARABEN SODIUM | ORAL | TABLET, ORALLY DISINTEGRATING | 5026620 | CR6K9C2NHK | 0.3mg | ||
| METHYLPYRROLIDONE | PERIODONTAL | SYSTEM | 872504 | JR9CE63FPM | 0.63mg/mg | ||
| METHYLPYRROLIDONE | SUBCUTANEOUS | INJECTION | 872504 | JR9CE63FPM | 194mg | ||
| METHYLPYRROLIDONE | SUBCUTANEOUS | INJECTION, SUSPENSION | 872504 | JR9CE63FPM | 376mg | ||
| MICROCRYSTALLINE CELLULOSE | BUCCAL | TABLET | 9004346 | OP1R32D61U | 18mg | ||
| MICROCRYSTALLINE CELLULOSE | INTRAVITREAL | IMPLANT | 9004346 | OP1R32D61U | 1.66mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | CAPSULE | 9004346 | OP1R32D61U | 2169mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | CAPSULE, COATED PELLETS | 9004346 | OP1R32D61U | 456mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | CAPSULE, DELAYED RELEASE | 9004346 | OP1R32D61U | 366mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | CAPSULE, EXTENDED RELEASE | 9004346 | OP1R32D61U | 1246mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | CAPSULE, GELATIN COATED | 9004346 | OP1R32D61U | 62mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | GRANULE | 9004346 | OP1R32D61U | 29520mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | GRANULE, DELAYED RELEASE | 9004346 | OP1R32D61U | 789.6mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | GRANULE, FOR SUSPENSION | OP1R32D61U | 173mg | |||
| MICROCRYSTALLINE CELLULOSE | ORAL | PELLET | 9004346 | OP1R32D61U | 1140mg | Y | |
| MICROCRYSTALLINE CELLULOSE | ORAL | POWDER, FOR SOLUTION | 9004346 | OP1R32D61U | 690mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | POWDER, FOR SUSPENSION | 9004346 | OP1R32D61U | 4441mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | SUSPENSION | 9004346 | OP1R32D61U | 1285mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | SUSPENSION, EXTENDED RELEASE | 9004346 | OP1R32D61U | 1120mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | TABLET | 9004346 | OP1R32D61U | 5117mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | TABLET, CHEWABLE | OP1R32D61U | 1725mg | |||
| MICROCRYSTALLINE CELLULOSE | ORAL | TABLET, CHEWABLE, EXTENDED RELEASE | 9004346 | OP1R32D61U | 144mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | TABLET, COATED | 9004346 | OP1R32D61U | 920mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | TABLET, DELAYED RELEASE | 9004346 | OP1R32D61U | 2210mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | TABLET, DELAYED RELEASE PARTICLES | 9004346 | OP1R32D61U | 580mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | TABLET, EXTENDED RELEASE | OP1R32D61U | 3679mg | |||
| MICROCRYSTALLINE CELLULOSE | ORAL | TABLET, FILM COATED | 9004346 | OP1R32D61U | 992mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004346 | OP1R32D61U | 615mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | TABLET, FOR SUSPENSION | 9004346 | OP1R32D61U | 20100mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | TABLET, ORALLY DISINTEGRATING | 9004346 | OP1R32D61U | 1800mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 9004346 | OP1R32D61U | 1576mg | ||
| MICROCRYSTALLINE CELLULOSE | ORAL | TROCHE | 9004346 | OP1R32D61U | 250mg | ||
| MICROCRYSTALLINE CELLULOSE | SUBLINGUAL | TABLET | 9004346 | OP1R32D61U | 43.2mg | ||
| MICROCRYSTALLINE WAX | ORAL | CAPSULE, EXTENDED RELEASE | 63231607 | XOF597Q3KY | 6mg | ||
| MICROCRYSTALLINE WAX | TOPICAL | CREAM | 63231607 | XOF597Q3KY | 0.45%w/w | ||
| MICROCRYSTALLINE WAX | TOPICAL | GEL | 63231607 | XOF597Q3KY | NA | ||
| MICROCRYSTALLINE WAX | TOPICAL | OINTMENT | 63231607 | XOF597Q3KY | 3575mg | ||
| MICROCRYSTALLINE WAX | VAGINAL | CREAM | 63231607 | XOF597Q3KY | 0.45%w/w | ||
| MILK PROTEIN CONCENTRATE | BUCCAL | TABLET | 871QYF3I7B | 27.43mg | |||
| MINERAL OIL | AURICULAR (OTIC) | OINTMENT | 8042475 | T5L8T28FGP | NA | ||
| MINERAL OIL | AURICULAR (OTIC) | SUSPENSION | 8042475 | T5L8T28FGP | 0.5%w/v | ||
| MINERAL OIL | DENTAL | PASTE | 8042475 | T5L8T28FGP | 95%w/w | ||
| MINERAL OIL | OPHTHALMIC | OINTMENT | 8042475 | T5L8T28FGP | 59.5%w/w | ||
| MINERAL OIL | OPHTHALMIC | SUSPENSION | 8042475 | T5L8T28FGP | 0.1%w/w | ||
| MINERAL OIL | ORAL | CAPSULE | 8042475 | T5L8T28FGP | 120mg | ||
| MINERAL OIL | ORAL | CAPSULE, EXTENDED RELEASE | 8042475 | T5L8T28FGP | 50mg | ||
| MINERAL OIL | ORAL | DROPS | 8042475 | T5L8T28FGP | NA | ||
| MINERAL OIL | ORAL | TABLET | 8042475 | T5L8T28FGP | 113.75mg | ||
| MINERAL OIL | ORAL | TABLET, CHEWABLE | 8042475 | T5L8T28FGP | 6mg | ||
| MINERAL OIL | ORAL | TABLET, COATED | 8042475 | T5L8T28FGP | 1.5mg | ||
| MINERAL OIL | ORAL | TABLET, DELAYED RELEASE | 8042475 | T5L8T28FGP | 5.67mg | ||
| MINERAL OIL | ORAL | TABLET, EXTENDED RELEASE | 8042475 | T5L8T28FGP | NA | ||
| MINERAL OIL | ORAL | TABLET, FILM COATED | 8042475 | T5L8T28FGP | NA | ||
| MINERAL OIL | RECTAL | SUPPOSITORY | 8042475 | T5L8T28FGP | NA | ||
| MINERAL OIL | TOPICAL | CREAM | 8042475 | T5L8T28FGP | 2772mg | ||
| MINERAL OIL | TOPICAL | CREAM, AUGMENTED | 8042475 | T5L8T28FGP | 23.63%w/w | ||
| MINERAL OIL | TOPICAL | GEL | 8042475 | T5L8T28FGP | 2.5%w/w | ||
| MINERAL OIL | TOPICAL | LOTION | 8042475 | T5L8T28FGP | 1428mg | ||
| MINERAL OIL | TOPICAL | OIL | 8042475 | T5L8T28FGP | 43.29%v/v | ||
| MINERAL OIL | TOPICAL | OINTMENT | 8042475 | T5L8T28FGP | 9938mg | Y | |
| MINERAL OIL | TOPICAL | PASTE | 8042475 | T5L8T28FGP | 47.5%w/w | ||
| MINERAL OIL | TOPICAL | SOAP | 8042475 | T5L8T28FGP | 0.82%w/w | ||
| MINERAL OIL | TOPICAL | SPRAY | 8042475 | T5L8T28FGP | 1379mg | ||
| MINERAL OIL | TOPICAL | SUSPENSION | 8042475 | T5L8T28FGP | 82%w/w | ||
| MINERAL OIL | TOPICAL | SYSTEM | 8042475 | T5L8T28FGP | 654.36mg | ||
| MINERAL OIL | TRANSDERMAL | FILM | 8042475 | T5L8T28FGP | 11.42mg | ||
| MINERAL OIL | TRANSDERMAL | FILM, EXTENDED RELEASE | 8042475 | T5L8T28FGP | 34mg | ||
| MINERAL OIL | TRANSDERMAL | SYSTEM | 8042475 | T5L8T28FGP | 6.09mg | ||
| MINERAL OIL | VAGINAL | CREAM | 8042475 | T5L8T28FGP | 15%w/w | ||
| MINERAL OIL | VAGINAL | SUPPOSITORY | 8042475 | T5L8T28FGP | 30mg | ||
| MIRIPIRIUM CHLORIDE | INTRA-ARTICULAR | INJECTION | 2748881 | 3D6CWI0P23 | 0.02%w/v | ||
| MIRIPIRIUM CHLORIDE | INTRA-ARTICULAR | INJECTION, SUSPENSION | 2748881 | 3D6CWI0P23 | 0.02%w/v | ||
| MIRIPIRIUM CHLORIDE | INTRALESIONAL | INJECTION | 2748881 | 3D6CWI0P23 | 0.02%w/v | ||
| MIRIPIRIUM CHLORIDE | INTRALESIONAL | INJECTION, SUSPENSION | 2748881 | 3D6CWI0P23 | 0.02%w/v | ||
| MIRIPIRIUM CHLORIDE | INTRAMUSCULAR | INJECTION | 2748881 | 3D6CWI0P23 | 0.02%w/v | ||
| MIRIPIRIUM CHLORIDE | INTRAMUSCULAR | INJECTION, SUSPENSION | 2748881 | 3D6CWI0P23 | 0.02%w/v | ||
| MIRIPIRIUM CHLORIDE | INTRASYNOVIAL | INJECTION, SUSPENSION | 2748881 | 3D6CWI0P23 | 0.02%w/v | ||
| MIRIPIRIUM CHLORIDE | SOFT TISSUE | INJECTION | 2748881 | 3D6CWI0P23 | 0.02%w/v | ||
| MIRIPIRIUM CHLORIDE | SOFT TISSUE | INJECTION, SUSPENSION | 2748881 | 3D6CWI0P23 | 0.02%w/v | ||
| MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | ORAL | CAPSULE | 461P5CJN6T | 107mg | |||
| MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | ORAL | SUSPENSION | 461P5CJN6T | 920mg | |||
| MONO AND DIGLYCERIDE | ORAL | CAPSULE | NA | 289.47mg | |||
| MONO AND DIGLYCERIDE | ORAL | CAPSULE, DELAYED RELEASE | NA | 68mg | |||
| MONO AND DIGLYCERIDE | TOPICAL | AEROSOL, FOAM | NA | 0.54%w/w | |||
| MONO AND DIGLYCERIDE | TOPICAL | CREAM | NA | 15%w/w | |||
| MONO AND DIGLYCERIDE | TOPICAL | CREAM, AUGMENTED | NA | 1%w/w | |||
| MONO AND DIGLYCERIDE | TOPICAL | OINTMENT | NA | 7%w/w | |||
| MONO AND DIGLYCERIDE | VAGINAL | CREAM | NA | 160mg | |||
| MONOBASIC POTASSIUM PHOSPHATE | AURICULAR (OTIC) | SOLUTION | 7778770 | 4J9FJ0HL51 | 0.2%w/w | ||
| MONOBASIC POTASSIUM PHOSPHATE | INTRA-ARTICULAR | INJECTION | 7778770 | 4J9FJ0HL51 | 0.3%w/v | ||
| MONOBASIC POTASSIUM PHOSPHATE | INTRAMUSCULAR | INJECTION | 7778770 | 4J9FJ0HL51 | 0.3%w/v | ||
| MONOBASIC POTASSIUM PHOSPHATE | INTRAVENOUS | INJECTION | 7778770 | 4J9FJ0HL51 | 68mg | ||
| MONOBASIC POTASSIUM PHOSPHATE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7778770 | 4J9FJ0HL51 | 110mg | ||
| MONOBASIC POTASSIUM PHOSPHATE | INTRAVENOUS | INJECTION, SOLUTION | 7778770 | 4J9FJ0HL51 | 1.36%w/v | ||
| MONOBASIC POTASSIUM PHOSPHATE | INTRAVESICAL | INJECTION, SOLUTION | 7778770 | 4J9FJ0HL51 | 29.2mg | ||
| MONOBASIC POTASSIUM PHOSPHATE | NASAL | SOLUTION | 7778770 | 4J9FJ0HL51 | 680mg | ||
| MONOBASIC POTASSIUM PHOSPHATE | NASAL | SPRAY | 7778770 | 4J9FJ0HL51 | 3mg | ||
| MONOBASIC POTASSIUM PHOSPHATE | OPHTHALMIC | SOLUTION | 7778770 | 4J9FJ0HL51 | 0.2%w/w | ||
| MONOBASIC POTASSIUM PHOSPHATE | OPHTHALMIC | SUSPENSION | 7778770 | 4J9FJ0HL51 | 0.44%w/w | ||
| MONOBASIC POTASSIUM PHOSPHATE | ORAL | CAPSULE, COATED PELLETS | 7778770 | 4J9FJ0HL51 | 17mg | ||
| MONOBASIC POTASSIUM PHOSPHATE | ORAL | SOLUTION | 7778770 | 4J9FJ0HL51 | 287mg | ||
| MONOBASIC POTASSIUM PHOSPHATE | ORAL | SUSPENSION | 7778770 | 4J9FJ0HL51 | 50mg/5ml | ||
| MONOBASIC POTASSIUM PHOSPHATE | ORAL | SYRUP | 7778770 | 4J9FJ0HL51 | 19mg | ||
| MONOBASIC POTASSIUM PHOSPHATE | ORAL | TABLET | 7778770 | 4J9FJ0HL51 | 25mg | ||
| MONOBASIC POTASSIUM PHOSPHATE | ORAL | TABLET, EXTENDED RELEASE | 7778770 | 4J9FJ0HL51 | 4mg | ||
| MONOBASIC POTASSIUM PHOSPHATE | SUBCUTANEOUS | INJECTION | 7778770 | 4J9FJ0HL51 | 8mg | ||
| MONOSODIUM CITRATE | ORAL | GRANULE, EFFERVESCENT | 18996355 | 68538UP9SE | NA | ||
| MONOSODIUM CITRATE | ORAL | POWDER, FOR SUSPENSION | 18996355 | 68538UP9SE | 550mg | ||
| MONOSODIUM CITRATE | ORAL | SUSPENSION | 18996355 | 68538UP9SE | 275mg | ||
| MONOSODIUM CITRATE | ORAL | TABLET | 18996355 | 68538UP9SE | 50mg | ||
| MONOSODIUM CITRATE | ORAL | TABLET, EFFERVESCENT | 18996355 | 68538UP9SE | 1900mg | ||
| MONOSODIUM CITRATE | ORAL | TABLET, ORALLY DISINTEGRATING | 18996355 | 68538UP9SE | 23mg | ||
| MONOSODIUM GLUTAMATE | BUCCAL | MOUTHWASH | 6106043 | W81N5U6R6U | 0.2mg/1ml | ||
| MONOSTEARYL CITRATE | TOPICAL | OINTMENT | 1337333 | YWW937R1QR | 0.75%w/w | ||
| MONOTHIOGLYCEROL | INFILTRATION | INJECTION, SOLUTION | 96275 | AAO1P0WSXJ | NA | ||
| MONOTHIOGLYCEROL | INTRAMUSCULAR | INJECTION | 96275 | AAO1P0WSXJ | 25mg | ||
| MONOTHIOGLYCEROL | INTRAMUSCULAR | SOLUTION | 96275 | AAO1P0WSXJ | 25mg | ||
| MONOTHIOGLYCEROL | INTRAVENOUS | INJECTION | 96275 | AAO1P0WSXJ | 25mg | ||
| MONOTHIOGLYCEROL | INTRAVENOUS | INJECTION, SOLUTION | 96275 | AAO1P0WSXJ | 158mg | ||
| MONOTHIOGLYCEROL | INTRAVENOUS | SOLUTION | 96275 | AAO1P0WSXJ | 25mg | ||
| MONOTHIOGLYCEROL | SUBCUTANEOUS | INJECTION | 96275 | AAO1P0WSXJ | 0.5%w/v | ||
| MONTAN WAX | ORAL | TABLET | 8002537 | N2TH4S4KUD | 0.06mg | ||
| MONTAN WAX | ORAL | TABLET, COATED | 8002537 | N2TH4S4KUD | 0.05mg | ||
| MONTAN WAX | ORAL | TABLET, FILM COATED | 8002537 | N2TH4S4KUD | 0.03mg | ||
| MULTISTEROL EXTRACT | TOPICAL | CREAM | NA | NA | |||
| MYRISTIC ACID | ORAL | CAPSULE, EXTENDED RELEASE | 544638 | 0I3V7S25AW | 430mg | ||
| MYRISTIC ACID | VAGINAL | AEROSOL, FOAM | 544638 | 0I3V7S25AW | 2%w/w | ||
| MYRISTYL ALCOHOL | ORAL | TABLET, EXTENDED RELEASE | 112721 | V42034O9PU | 2mg | ||
| MYRISTYL ALCOHOL | TOPICAL | AEROSOL, FOAM | 112721 | V42034O9PU | 2.5%w/w | ||
| MYRISTYL ALCOHOL | TOPICAL | CREAM | 112721 | V42034O9PU | 3%w/w | ||
| MYRISTYL ALCOHOL | TOPICAL | LOTION | 112721 | V42034O9PU | 1%w/w | ||
| MYRISTYL ALCOHOL | TOPICAL | SUSPENSION | 112721 | V42034O9PU | 1.05%w/w | ||
| MYRISTYL LACTATE | TOPICAL | LOTION | 1323031 | 1D822OC34X | 0.8%w/w | ||
| MYVACET TYPE 5-00 | ORAL | TABLET | 8029912 | NA | NA | ||
| MYVACET TYPE 5-00 | ORAL | TABLET, COATED | 8029912 | NA | 0.31mg | ||
| MYVACET TYPE 5-00 | ORAL | TABLET, EXTENDED RELEASE | 8029912 | NA | 0.04mg |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: January 5, 2024
Database Last Updated: January 26, 2024